Most-Downgraded StocksMost-DowngradedNASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free DCGO Stock Alerts $3.03 -0.01 (-0.33%) (As of 12:14 PM ET) Add Compare Share Share Today's Range$3.01▼$3.0650-Day Range$3.02▼$4.0952-Week Range$2.78▼$10.82Volume135,763 shsAverage Volume1.42 million shsMarket Capitalization$307.76 millionP/E Ratio15.15Dividend YieldN/APrice Target$7.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get DocGo alerts: Email Address DocGo MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside154.9% Upside$7.75 Price TargetShort InterestHealthy10.25% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.71Based on 4 Articles This WeekInsider TradingAcquiring Shares$146,150 Bought Last QuarterProj. Earnings Growth-50.00%From $0.24 to $0.12 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.02 out of 5 starsMedical Sector161st out of 918 stocksHealth Services Industry2nd out of 10 stocks 4.5 Analyst's Opinion Consensus RatingDocGo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageDocGo has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about DocGo's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted10.25% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in DocGo has recently decreased by 6.26%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DCGO. Previous Next 2.6 News and Social Media Coverage News SentimentDocGo has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for DocGo this week, compared to 4 articles on an average week.Search Interest1 people have searched for DCGO on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added DocGo to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $146,150.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders13.78% of the stock of DocGo is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for DocGo are expected to decrease by -50.00% in the coming year, from $0.24 to $0.12 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is 15.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.51.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is 15.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 124.76.Price to Earnings Growth RatioDocGo has a PEG Ratio of 1.54. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDocGo has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about DocGo's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. About DocGo Stock (NASDAQ:DCGO)DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Read More DCGO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DCGO Stock News HeadlinesMay 14, 2024 | insidertrades.comDocGo Inc. (NASDAQ:DCGO) General Counsel Purchases $31,300.00 in StockMay 21 at 7:35 AM | businesswire.comDocGo Announces Upcoming Participation at Stifel Cross Sector Insight ConferenceMay 14, 2024 | americanbankingnews.comDocGo Inc. (NASDAQ:DCGO) Receives Consensus Recommendation of "Buy" from BrokeragesMay 14, 2024 | americanbankingnews.comDocGo Inc. (NASDAQ:DCGO) General Counsel Ely D. Tendler Acquires 10,000 SharesMay 14, 2024 | americanbankingnews.comDocGo Inc. (NASDAQ:DCGO) CEO Lee Bienstock Buys 25,000 SharesMay 13, 2024 | americanbankingnews.comDocGo (NASDAQ:DCGO) Price Target Cut to $5.00 by Analysts at Canaccord Genuity GroupMay 13, 2024 | americanbankingnews.comBTIG Research Trims DocGo (NASDAQ:DCGO) Target Price to $7.00May 13, 2024 | americanbankingnews.comDocGo (NASDAQ:DCGO) PT Lowered to $5.00May 13, 2024 | americanbankingnews.comNorthland Capmk Comments on DocGo Inc.'s Q1 2025 Earnings (NASDAQ:DCGO)May 13, 2024 | americanbankingnews.comDocGo (NASDAQ:DCGO) Price Target Cut to $7.00May 12, 2024 | finance.yahoo.comDocGo Inc. (NASDAQ:DCGO) Q1 2024 Earnings Call TranscriptMay 11, 2024 | americanbankingnews.comQ3 2024 EPS Estimates for DocGo Inc. Reduced by Northland Capmk (NASDAQ:DCGO)May 10, 2024 | finance.yahoo.comDocGo Inc (DCGO) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 PerformanceMay 10, 2024 | finance.yahoo.comDocGo First Quarter 2024 Earnings: EPS Beats ExpectationsMay 9, 2024 | markets.businessinsider.comBuy Rating on DocGo: Strong Growth Potential and Financial Health Despite Revenue Base ChangesMay 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: DocGo (DCGO), Avadel Pharmaceuticals (AVDL)May 9, 2024 | finance.yahoo.comDocGo Inc (DCGO) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and Strategic ...May 8, 2024 | investorplace.comDCGO Stock Earnings: DocGo Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | finance.yahoo.comDocGo Announces Strong First Quarter 2024 ResultsMay 8, 2024 | finance.yahoo.comWith 52% ownership of the shares, DocGo Inc. (NASDAQ:DCGO) is heavily dominated by institutional ownersMay 1, 2024 | nasdaq.comDocGo Inc. Common Stock (DCGO)April 30, 2024 | markets.businessinsider.comEvaluating DocGo: Insights From 8 Financial AnalystsApril 22, 2024 | businesswire.comDocGo to Announce First Quarter 2024 Results on Wednesday, May 8, 2024April 17, 2024 | msn.comDocGo (DCGO) Price Target Decreased by 7.98% to 10.08April 12, 2024 | investing.comStifel cuts DocGo stock target, maintains buy amid contract shiftSee More Headlines Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today5/21/2024Next Earnings (Estimated)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:DCGO CUSIPN/A CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees4,164Year FoundedN/APrice Target and Rating Average Stock Price Target$7.75 High Stock Price Target$16.00 Low Stock Price Target$5.00 Potential Upside/Downside+154.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.20 Trailing P/E Ratio15.20 Forward P/E Ratio12.67 P/E Growth1.54Net Income$6.86 million Net Margins2.98% Pretax Margin5.41% Return on Equity6.20% Return on Assets4.14% Debt Debt-to-Equity RatioN/A Current Ratio2.09 Quick Ratio2.09 Sales & Book Value Annual Sales$624.29 million Price / Sales0.49 Cash Flow$0.21 per share Price / Cash Flow14.47 Book Value$2.93 per share Price / Book1.04Miscellaneous Outstanding Shares101,570,000Free Float87,570,000Market Cap$308.77 million OptionableOptionable Beta0.96 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Lee Bienstock (Age 39)CEO & Director Comp: $2.21MMr. Norman Rosenberg (Age 54)Treasurer & CFO Comp: $1.43MMr. Ely D. Tendler (Age 56)General Counsel, Secretary & Director Comp: $926.37kMr. Stephen Sugrue (Age 51)Chief Compliance Officer Comp: $864.35kMr. Andre Oberholzer CPA (Age 65)Executive Vice President of Strategy Comp: $1.48MMike ColeVice President of Investor RelationsMs. Rosemarie MilanoVice President of Human ResourcesMr. Aaron SeversChief Product OfficerMs. Vrenely MunozChief Revenue OfficerDr. James PowellChief Executive Officer of Clinical Practice GroupMore ExecutivesKey CompetitorsSharecareNASDAQ:SHCRQuantum-SiNASDAQ:QSIP3 Health PartnersNASDAQ:PIIITalkspaceNASDAQ:TALKAgroFresh SolutionsNASDAQ:AGFSView All CompetitorsInsiders & InstitutionsKennedy Capital Management LLCSold 314,520 shares on 5/16/2024Ownership: 1.418%Janus Henderson Group PLCSold 12,216 shares on 5/16/2024Ownership: 0.332%Jacobs Levy Equity Management Inc.Bought 166,247 shares on 5/16/2024Ownership: 0.160%California State Teachers Retirement SystemSold 4,146 shares on 5/16/2024Ownership: 0.084%Price T Rowe Associates Inc. MDBought 11,174 shares on 5/15/2024Ownership: 0.045%View All Insider TransactionsView All Institutional Transactions DCGO Stock Analysis - Frequently Asked Questions Should I buy or sell DocGo stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DCGO shares. View DCGO analyst ratings or view top-rated stocks. What is DocGo's stock price target for 2024? 5 analysts have issued 12-month price targets for DocGo's shares. Their DCGO share price targets range from $5.00 to $16.00. On average, they expect the company's share price to reach $7.75 in the next year. This suggests a possible upside of 154.9% from the stock's current price. View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts. How have DCGO shares performed in 2024? DocGo's stock was trading at $5.59 on January 1st, 2024. Since then, DCGO shares have decreased by 45.6% and is now trading at $3.04. View the best growth stocks for 2024 here. When is DocGo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 5th 2024. View our DCGO earnings forecast. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) posted its quarterly earnings data on Wednesday, February, 28th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.07. The business had revenue of $199.25 million for the quarter, compared to analysts' expectations of $195.48 million. DocGo had a net margin of 2.98% and a trailing twelve-month return on equity of 6.20%. What ETF holds DocGo's stock? Global X Telemedicine & Digital Health ETF holds 96,570 shares of DCGO stock, representing 0.69% of its portfolio. What guidance has DocGo issued on next quarter's earnings? DocGo issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600.0 million-$650.0 million, compared to the consensus revenue estimate of $714.3 million. Who are DocGo's major shareholders? DocGo's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.66%), WCM Investment Management LLC (2.52%), Kennedy Capital Management LLC (1.42%), Isthmus Partners LLC (0.58%), Pasadena Private Wealth LLC (0.38%) and Janus Henderson Group PLC (0.33%). Insiders that own company stock include Adriaan Stephanus Oberholzer, Anthony Capone, Ely D Tendler, James M Travers, Lee Bienstock, Michael J Burdiek and Stephen Sugrue. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DCGO) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.